Previous 10 | Next 10 |
The following slide deck was published by Achieve Life Sciences, Inc. in conjunction with this Read more ...
Lake Street initiated Achieve Life Sciences ( ACHV +11.0% ) with a Buy rating, PT $30; past 6 months the stock has generated 117%. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Stocks on the move, Read more ...
SEATTLE and VANCOUVER, BC , Sept. 10, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that cytisinicline data w...
SEATTLE and VANCOUVER, BC , Sept. 3, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that it will present at ...
Achieve Life Sciences, Inc. (ACHV) Q2 2020 Earnings Conference Call August 6, 2020 16:30 ET Company Participants Jaime Xinos - Executive Vice President of Commercial Richard Stewart - Chief Executive Officer Cindy Jacobs - Executive Vice President & Chief Medical Officer Jo...
Achieve Life Sciences (NASDAQ: ACHV ) : Q2 GAAP EPS of -$1.68 beats by $0.79 . More news on: Achieve Life Sciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
SEATTLE and VANCOUVER, British Columbia , Aug. 6, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today ...
Achieve Life Sciences (NASDAQ: ACHV ) down ~7% premarket, after pricing its previously announced public offering of ~476k shares at $10.50/share, discount of ~10% of last close of $11.72. More news on: Achieve Life Sciences, Inc., Stocks on the move, Healthcare stocks news,...
SEATTLE and VANCOUVER, BC , Aug. 4, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced t...
SEATTLE and VANCOUVER, BC, Aug. 3, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced a...
News, Short Squeeze, Breakout and More Instantly...
Achieve Life Sciences Inc. Company Name:
ACHV Stock Symbol:
NASDAQ Market:
Achieve Life Sciences Inc. Website:
– Two New Independent Directors, Stuart Duty and Andrew Saik, Appointed – Third New Independent Director to Be Appointed to Board in Near Term MONTREAL and CHARLOTTE, N.C., July 15, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) (...
SEATTLE and VANCOUVER, British Columbia, July 09, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced that...
SEATTLE and VANCOUVER, British Columbia, July 01, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, announced that the c...